Lung Cancer Trial, Recruiting NCT06816121 Sponsor: Everest Detection, Inc. Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06816121
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who understand the study and are able to sign a written consent form
  • People who are willing and able to provide a blood sample
  • People aged between 30 and 80 years old
  • People who currently smoke or have smoked in the past
  • People in the "no cancer" group: those who have had a CT scan in the last 3 months showing no lung nodules, or only nodules considered harmless or unchanged
  • People in the "uncertain nodule" group: those who have had a CT scan in the last 12 months showing lung nodules that are unclear and being monitored
  • People in the "suspicious or confirmed lung cancer" group: those who have confirmed lung cancer that has not yet been treated, or lung nodules that look highly suspicious and are currently being investigated
  • People in the "other cancer" group: those who have a confirmed, untreated cancer that is linked to smoking

Who may not be able to join:

  • People who have been diagnosed with any cancer in the last 5 years
  • People who have received cancer treatment such as chemotherapy, radiation, or surgery within the past year
  • People with any history of blood cancers or a condition called myelodysplasia, which affects blood cell production
  • People known to be living with HIV, hepatitis C (HCV), or hepatitis B (HBV)
  • People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 786.542.2122

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Everest Detection, Inc.
Registry
ClinicalTrials.gov
Start date
17 February 2025
Est. completion
30 June 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Biomarker Discovery and Validation for Blood-Based Early Lung Cancer Detection in Heavy Smokers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov